Health & Environment
Zydus Lifesciences receives five US FDA observations at Gujarat plant
The Hindu1h
THE BRIEF
1
The United States Food and Drug Administration issued five inspection observations to Zydus Lifesciences' manufacturing facility in Moraiya, Ahmedabad.
2
The regulatory inspection was conducted between October 5 and October 13, 2026, before closing with the reported findings.
3
The pharmaceutical company stated it will work closely with the US regulator to address the issued observations expeditiously.